Outlook Therapeutics (OTLK) Net Margin Growth (1y) (2016 - 2019)
Outlook Therapeutics (OTLK) Net Margin Growth (1y) (2016 - 2019) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
3,245.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
1,120.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Outlook Therapeutics |
51.13 Mn |
43.39 Mn |
-21,888.00 |
- |
| Date | Value |
|---|
| Sep 30, 2019 |
146,355.00 |
| Jun 30, 2019 |
38,921.00 |
| Mar 31, 2019 |
-65,218.00 |
| Dec 31, 2018 |
136,988.00 |
| Sep 30, 2018 |
-137,865.00 |
| Jun 30, 2018 |
58,180.00 |
| Mar 31, 2018 |
154,548.00 |
| Dec 31, 2017 |
400,373.00 |
| Sep 30, 2017 |
187,524.00 |
| Jun 30, 2017 |
434,248.00 |
| Mar 31, 2017 |
-219,459.00 |
| Dec 31, 2016 |
-451,070.00 |
| Sep 30, 2016 |
155,705.00 |
| Jun 30, 2016 |
-514,114.00 |
| Mar 31, 2016 |
258,821.00 |
